These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16030308)

  • 1. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
    Freeman SN; Bepler G; Haura E; Sutphen R; Cress WD
    J Natl Cancer Inst; 2005 Jul; 97(14):1088-9; author reply 1093-5. PubMed ID: 16030308
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
    Iglesias-Serret D; Coll-Mulet L; Santidrián AF; Navarro-Sabaté A; Domingo A; Pons G; Gil J
    J Natl Cancer Inst; 2005 Jul; 97(14):1090-1; author reply 1093-5. PubMed ID: 16030310
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
    Nenning UC; Eckert C; Wellmann S; Barth A; Henze G; Seeger K
    J Natl Cancer Inst; 2005 Jul; 97(14):1091-2; author reply 1093-5. PubMed ID: 16030311
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
    Dicker F; Rauhut S; Kohlmann A; Kern W; Schoch C; Haferlach T; Schnittger S
    J Natl Cancer Inst; 2005 Jul; 97(14):1092-3; author reply 1093-5. PubMed ID: 16030312
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
    Vargas RL; Felgar RE; Rothberg PG
    J Natl Cancer Inst; 2005 Jul; 97(14):1089-90; author reply 1093-5. PubMed ID: 16030309
    [No Abstract]   [Full Text] [Related]  

  • 6. The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cells.
    Coenen S; Pickering B; Potter KN; Johnson PW; Stevenson FK; Packham G
    Haematologica; 2005 Sep; 90(9):1285-6. PubMed ID: 16154859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
    Moshynska O; Sankaran K; Pahwa P; Saxena A
    J Natl Cancer Inst; 2004 May; 96(9):673-82. PubMed ID: 15126604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
    Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
    J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia.
    Tobin G; Skogsberg A; Thunberg U; Laurell A; Aleskog A; Merup M; Sundström C; Roos G; Nilsson K; Rosenquist R
    Leukemia; 2005 May; 19(5):871-3. PubMed ID: 15759030
    [No Abstract]   [Full Text] [Related]  

  • 10. Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia.
    Véronèse L; Tournilhac O; Verrelle P; Davi F; Dighiero G; Chautard E; Veyrat-Masson R; Kwiatkowski F; Goumy C; Gouas L; Bay JO; Vago P; Tchirkov A
    Leuk Res; 2009 Dec; 33(12):1623-6. PubMed ID: 19487028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCL-1 promoter insertions dial-up aggressiveness of chronic leukemia.
    Kitada S; Reed JC
    J Natl Cancer Inst; 2004 May; 96(9):642-3. PubMed ID: 15126592
    [No Abstract]   [Full Text] [Related]  

  • 12. Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia.
    Véronèse L; Tournilhac O; Verrelle P; Davi F; Dighiero G; Chautard E; Veyrat-Masson R; Kwiatkowski F; Goumy C; Vago P; Travade P; Tchirkov A
    Leukemia; 2008 Jun; 22(6):1291-3. PubMed ID: 18046444
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of cell death of chronic lymphocytic leukemia lymphocytes by RNA-directed agent, 8-NH2-adenosine.
    Balakrishnan K; Wierda WG; Keating MJ; Gandhi V
    Clin Cancer Res; 2005 Sep; 11(18):6745-52. PubMed ID: 16166456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short nucleotide polymorphic insertions in the MCL-1 promoter affect gene expression.
    Saxena A; Moshynska OV; Moshynskyy ID; Neuls ED; Qureshi T; Bosch M; Voralia M; Bonham K
    Cancer Lett; 2007 Jun; 251(1):114-31. PubMed ID: 17198743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia.
    Papageorgiou SG; Lambropoulos S; Pappa V; Economopoulou C; Kontsioti F; Papageorgiou E; Tsirigotis P; Dervenoulas J; Economopoulos T
    Am J Hematol; 2007 Sep; 82(9):824-5. PubMed ID: 17546638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of chronic lymphocytic leukemia: implications for therapy.
    Reed JC
    Semin Hematol; 1998 Jul; 35(3 Suppl 3):3-13. PubMed ID: 9685174
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of vascular endothelial growth factor on apoptosis and expression of Bcl-2 and Mcl-1 in acute leukemia cells].
    Liao XL; Xie XT; Li BS; Li L; Yang LL
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):491-5. PubMed ID: 17178043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanism.
    Gao N; Kramer L; Rahmani M; Dent P; Grant S
    Mol Pharmacol; 2006 Aug; 70(2):645-55. PubMed ID: 16672643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progression-free survival.
    Nückel H; Frey UH; Sellmann L; Bau M; Dürig J; Dührsen U; Siffert W
    Leukemia; 2006 Apr; 20(4):724. PubMed ID: 16453002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.